Piper Sandler analyst James Fish maintains Fastly (NYSE:FSLY) with a Neutral and raises the price target from $10 to $14.
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.